glp-1 non responders Why Some Patients Do Not Respond to Therapies When GLP-1s Fall Short: Some

L.Casado-DazA.et al (2020)

Studies have shown that integrating these approaches with standard RA treatments like methotrexate or biologics may offer a comprehensive strategy to manage RA by addressing both immune dysregulation and oxidative stress (78, 128, 129)

Considering the established involvement of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway and transforming growth factor-beta1 (TGF-1) in RA, this research aimed to assess efficacy and safety of L-carnitine as an adjunct therapy targeting these pathways

It offers an alternative to injectable GLP-1 drugs

Question: What amino acids are essential